OVID
Ovid Therapeutics Inc.
Recent 8-K filings for OVID
Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.
-
May 12, 2026 11:04 UTC earnings item 2.02item 9.01
Ovid Q1 net loss $17M; raises $60M PIPE; dosed first OV4071 Phase 1; OV329 Phase 2 planned
source · OVID on sec.gov